ESC 365 - Mechanisms of cancer-related cardiomyopathy

Open Access

Mechanisms of cancer-related cardiomyopathy

Event: Frontiers in CardioVascular Biology 2016

Topic: Myocardium

Session type: Featured Symposium

Date: 8 July 2016

Time: 17:00 - 18:30

Session

6 presentations in this session

Sexual dimorphism of anthracycline cardiotoxicity

Speaker: Associate Professor M. Moulin (Chatenay-Malabry, FR)

AKAP signalling in chemotherapy-induced heart disease.

Speaker: Associate Professor D. Diviani (Lausanne, CH)

Targeting PI3Kgamma in cancer therapy: how to kill two birds with one stone.

Speaker: Associate Professor A. Ghigo (Turin, IT)

Protection against chemotherapy cardiotoxicity by the human amniotic fluid stem cell secretome: a new tool for future paracrine therapy.

Speaker: Assistant Professor S. Bollini (Genova, IT)

Hyperlipidaemia reduces mortality in breast, prostate, lung and bowel cancer

Speaker: Doctor P. Carter (London, GB)

DNA-repair in cardiomyocytes is critical for maintaining cardiac function

Speaker: Miss M. De Boer (Rotterdam, NL)

6 speakers from this session

Associate Professor Maryline Moulin

Inserm UMR-S 769, LabEx LERMIT, University Paris-Sud, Chatenay-Malabry (France)

1 presentation

0 follower

Associate Professor Dario Diviani

, Lausanne (Switzerland)

1 presentation

0 follower

Associate Professor Alessandra Ghigo

University of Turin - Molecular Biotechnology Center, Turin (Italy)

4 presentations

0 follower

Assistant Professor Sveva Bollini

University of Genova, Genova (Italy)

0 follower

Doctor Paul Richard Carter

University of Cambridge, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

Miss Martine De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

0 follower

This platform is supported by